RIGEL PHARMACEUTICALS INC
Tremor tracks 2 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
None right now.
Trials
- RIGLRigel Pharmaceuticals10Calm
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
Signing up patientsPhase 1/286 patientsMain results: Dec 2027 - RIGLRigel Pharmaceuticals0Calm
Study of Olutasidenib and Temozolomide in HGG
Signing up patientsPhase 260 patientsMain results: Jun 2029
Key executives leaving
From the last 12 months of the company's SEC reports.
None found.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
2 sales (0 not pre-planned) · 0 purchases
- Ali-Jackson KamilBoard member · Jun 22, 2026Sold 2,500 sharesabout $88 thousand · pre-planned
- Ali-Jackson KamilBoard member · May 26, 2026Sold 2,500 sharesabout $73 thousand · pre-planned
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.